Phenominer Database Results (36 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
GK/MolTac blood hemoglobin level control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 70 days-77 days 7 15.8 g/dl 0.34 0.9 automated hematology analysis 0.0 0 103851 2864
GK/MolTac hematocrit rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 122 days-129 days 5 53.4 % 1.25 2.8 automated hematology analysis 0.0 0 103870 2864
GK/MolTac hematocrit sodium chloride solution (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 164 days-171 days 7 58.1 % 0.6 1.6 automated hematology analysis 0.0 0 103872 2864
GK/MolTac hematocrit rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 164 days-171 days 7 54.8 % 1.85 4.9 automated hematology analysis 0.0 0 103873 2864
GK/MolTac blood hemoglobin A1c level control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 70 days-77 days 7 4.94 % 0.09 0.24 automated hematology analysis 0.0 0 103875 2864
GK/MolTac blood hemoglobin A1c level sodium chloride solution (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 7 5.19 % 0.05 0.14 automated hematology analysis 0.0 0 103878 2864
GK/MolTac blood hemoglobin A1c level sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 7 5.41 % 0.08 0.22 automated hematology analysis 0.0 0 103881 2864
GK/MolTac blood hemoglobin A1c level sodium chloride solution (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 7 6.89 % 0.61 1.61 automated hematology analysis 0.0 0 103884 2864
GK/MolTac blood hemoglobin level sodium chloride solution (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 7 17.9 g/dl 0.15 0.4 automated hematology analysis 0.0 0 103860 2864
GK/MolTac hematocrit rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 122 days-129 days 7 54.1 % 0.83 2.2 automated hematology analysis 0.0 0 103871 2864
GK/MolTac blood hemoglobin level control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 70 days-77 days 6 13.1 g/dl 1.18 2.9 automated hematology analysis 0.0 0 103852 2864
GK/MolTac blood hemoglobin level sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 7 16.2 g/dl 0.45 1.2 automated hematology analysis 0.0 0 103857 2864
GK/MolTac hematocrit control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 70 days-77 days 6 42.3 % 3.8 9.3 automated hematology analysis 0.0 0 103864 2864
GK/MolTac hematocrit control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 70 days-77 days 7 46.0 % 2.0 5.3 automated hematology analysis 0.0 0 103865 2864
GK/MolTac hematocrit rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 95 days-102 days 6 53.8 % 0.65 1.6 automated hematology analysis 0.0 0 103867 2864
GK/MolTac hematocrit control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 70 days-77 days 7 50.0 % 1.06 2.8 automated hematology analysis 0.0 0 103863 2864
GK/MolTac hematocrit sodium chloride solution (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 122 days-129 days 7 53.4 % 1.44 3.8 automated hematology analysis 0.0 0 103869 2864
GK/MolTac blood hemoglobin A1c level control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 70 days-77 days 6 4.75 % 0.06 0.14 automated hematology analysis 0.0 0 103876 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 5 5.2 % 0.1 0.22 automated hematology analysis 0.0 0 103882 2864
GK/MolTac blood hemoglobin level sodium chloride solution (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 7 16.1 g/dl 0.64 1.7 automated hematology analysis 0.0 0 103854 2864
GK/MolTac blood hemoglobin level rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 6 16.6 g/dl 0.2 0.5 automated hematology analysis 0.0 0 103855 2864
GK/MolTac blood hemoglobin level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 5 16.7 g/dl 0.72 1.6 automated hematology analysis 0.0 0 103861 2864
GK/MolTac hematocrit rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 95 days-102 days 7 49.8 % 1.4 3.7 automated hematology analysis 0.0 0 103868 2864
GK/MolTac hematocrit rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 164 days-171 days 7 57.7 % 0.23 0.6 automated hematology analysis 0.0 0 103874 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 6 4.95 % 0.06 0.15 automated hematology analysis 0.0 0 103879 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 7 4.86 % 0.1 0.27 automated hematology analysis 0.0 0 103880 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 7 5.19 % 0.08 0.2 automated hematology analysis 0.0 0 103883 2864
GK/MolTac blood hemoglobin level control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 70 days-77 days 7 14.4 g/dl 0.6 1.6 automated hematology analysis 0.0 0 103853 2864
GK/MolTac blood hemoglobin level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 5 16.3 g/dl 0.54 1.2 automated hematology analysis 0.0 0 103858 2864
GK/MolTac blood hemoglobin level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 122 days-129 days 7 17.0 g/dl 0.19 0.5 automated hematology analysis 0.0 0 103859 2864
GK/MolTac blood hemoglobin level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 7 17.8 g/dl 0.08 0.2 automated hematology analysis 0.0 0 103862 2864
GK/MolTac hematocrit sodium chloride solution (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. erythrocyte quantity male 95 days-102 days 7 51.1 % 2.8 7.4 automated hematology analysis 0.0 0 103866 2864
GK/MolTac blood hemoglobin A1c level control condition (between 70 and 77 days) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 70 days-77 days 7 4.8 % 0.07 0.19 automated hematology analysis 0.0 0 103877 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 7 5.86 % 0.24 0.64 automated hematology analysis 0.0 0 103885 2864
GK/MolTac blood hemoglobin A1c level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 60 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 164 days-171 days 7 5.61 % 0.12 0.32 automated hematology analysis 0.0 0 103886 2864
GK/MolTac blood hemoglobin level rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood hemoglobin amount male 95 days-102 days 7 15.4 g/dl 0.45 1.2 automated hematology analysis 0.0 0 103856 2864